$0.62 0.02 (+3.33%)
2/9/2010 3:58 PM

Arrowhead Research Corp (ARWR)

CAPS Rating: 3 out of 5

A development stage nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy.

Current Price $0.62 Mkt Cap $38.93M
Open $0.61 P/E Ratio 0.00
Prev. Close $0.60 Div. (Yield) N/A (N/A)
Daily Range $0.58 - $0.64 Volume 116,491
52-Wk Range $0.31 - $0.84 Avg. Daily Vol. 0

ARWR News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

97 Outperform
8 Underperform
 

All-Star Members

21 Outperform
3 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top ARWR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

robertvince (74.79)
Submitted April 27, 2007

Nanotechnology company that invests in other nanotechnology companies, sort of like TINY does. Arrowhead Research has a wonderful position in the Carbon Nanotube world which hasn't even begun to hit its stride. Recently merged one of its… More

1 Comment | Reply | Report this Post

alopex (99.60)
Submitted July 07, 2007

Wild mix of activities all aimed at attracting uncanny investors through broad band buzz-word bingo. Financials reflect that none of these areas are commercialized and probably will never be. Try to compete in semiconductor + pharma + nano-technology… More

0 Comments | Reply | Report this Post
ARWR VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about ARWR.

Recs

0
Member Avatar Fixitguy (< 20) Submitted: 5/1/2008 12:48:25 PM : Outperform Start Price: $2.68 ARWR Score: -56.17

They are doing research on carbon nanotubes, siRNA, even fullerenes from a Nobel Prize laureate. ARWR is like investing in a venture capital firm involved with leading edge tech and biotech.

Recently they spun off a company called Ensyse Biosciences, which is researching ways to use carbo nanotubes to shrink cancer tumor cells. One of the researchers, Dr. Steven Curley of the M. D. Anderson Cancer Center, is being funded by them. He was featured on a 60 Minutes segment recently.

The stock is volatile, and very small cap. But if the research projects they invest in take off, so will the share price.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar drod0886 (23.64) Submitted: 3/27/2008 1:01:31 PM : Outperform Start Price: $3.30 ARWR Score: -64.23

carbon nanotubes baby!

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar rlandrem (< 20) Submitted: 1/25/2008 6:32:59 PM : Outperform Start Price: $2.89 ARWR Score: -60.65

Gamble on!

Report this Post 0 Comments | Reply | Permalink
View All 28 Pitches »

Leaderboard

Find the members with the highest scoring picks in ARWR.

Score Leader

mansloth

mansloth (95.43) Score: +75.53

The Score Leader is the member with the highest score across all their picks in ARWR.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
mansloth 95.43 8/22/2006 Underperform 1Y $5.00 -87.60% -12.07% +75.53 1 Comment
KidThings 93.77 8/10/2007 Underperform 3Y $5.00 -87.60% -21.38% +66.22
Shevon883 49.27 1/26/2007 Underperform 1Y $4.00 -84.49% -19.81% +64.67 1 Comment
andrew161 < 20 6/22/2007 Underperform 3W $5.74 -89.20% -24.81% +64.39
NetscribeServcs < 20 2/20/2007 Underperform 1Y $3.98 -84.42% -21.82% +62.61 1 Comment
cajun021 36.89 1/10/2008 Underperform 5Y $3.35 -81.49% -20.00% +61.49 1 Comment
dzirak 89.69 10/29/2007 Underperform 1Y $4.62 -86.58% -26.95% +59.63
kevrose31 74.71 11/7/2007 Underperform 5Y $3.80 -83.68% -25.33% +58.35
Fixitguy < 20 5/1/2008 Outperform 3M $2.68 -76.87% -20.69% -56.17 1 Comment
Jchoiboy 21.21 11/6/2007 Outperform 5Y $3.69 -83.20% -25.54% -57.66 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackGlobalCrown < 20 4/24/2007 Outperform NS $6.17 -89.95% -23.41% -66.54

Featured Broker Partners